Suanfarma Suanfarma

X

Find the latest Drugs in Development and Pipeline Prospector News of North Star Processing, LLC..

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
North Star Processing, LLC.
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
245 E. Roselawn Ave., Suite 24, St. Paul, MN 55117, 651-765-4585
Telephone
Telephone
651-765-4585
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

Details:

MNPR-101-Zr is a zirconium-89 labeled version of MNPR-101, Monopar’s proprietary first-in-class humanized monoclonal antibody that is highly selective against uPAR. It is being developed for the treatment of triple-negative breast, colorectal, & pancreatic cancers.


Lead Product(s): MNPR-101-Zr

Therapeutic Area: Oncology Product Name: MNPR-101-Zr

Highest Development Status: IND EnablingProduct Type: Large molecule

Recipient: Monopar Therapeutics

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 27, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY